Document is current
Any future updates will be listed below
-
Authors
Strom, Jordan B.
Spetko, Nicholas
Song, Yang
Angell-James, Constance E. M.
Cassidy, Madeline A.
Stout, Jessica L.
Winburn, Morgan L.
Lee, Rebecca
Stone, Cosby A. Jr.
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (1R01HL169517)
National Heart, Lung, and Blood Institute (T32HL160522)
National Institute on Aging (1R01AG063937)
American Academy of Allergy, Asthma and Immunology Foundation
- License Information
-
More Information
Article History
Received: 26 August 2025
Accepted: 17 November 2025
First Online: 29 December 2025
Declarations
:
: The study was performed in accordance with the Declaration of Helsinki and approved by the institutional review boards at both BIDMC (Federal Wide Assurance # 00003245) and VUMC (Federal Wide Assurance #00005756) with verbal consent from patients for participation.
: Dr. Strom reports research grants from the National Heart, Lung, and Blood Institute (1R01HL169517, 1R01HL173998), Edwards Lifesciences, EchoIQ, Anumana, Viz.ai, EVERSANA Lifesciences; consulting for Bracco Diagnostics, Edwards Lifesciences, Philips Healthcare, General Electric Healthcare, and EVERSANA, and is a member of the scientific advisory boards for Ultromics, HeartSciences, Bristol Myers Squibb, Alnyam, Ultrasight, and EchoIQ. Dr. Stone received funding from the American Academy of Allergy, Asthma, and Immunology Foundation which supported this research. He reports additional grant support from AHRQ R01HS030234, NIAID U01AI181927, NIAID 1U01AI184071-01 and a pilot award for chemotherapy allergy research from the Vanderbilt Ingram Cancer Center/Chic Awearness. Funders played no role in any aspect of this manuscript. Dr. Stone reports consulting work for Larimar Therapeutics and Stallergenes Greer which is unrelated to the current work. All other authors report no relevant disclosures.
